FUST Fuse Group Holding

Document And Entity Information

Document And Entity InformationMar. 11, 2021
Document Information Line Items
Entity Registrant NameFuse Group Holding Inc.
Document Type8-K/A
Amendment Flagtrue
Amendment DescriptionFuse Group Holding Inc. (the “Company”) is filing this Amendment No. 1 (this “Amendment”) to amend its Current Report on Form 8-K, initially filed with the Securities and Exchange Commission on March 17, 2021 (the “Original 8-K”). The purpose of this Amendment is to expand the disclosure to clarify that E-Mo Biotech Holding Inc. is a start-up, development-stage company involving in vaccine, immunological treatment and diagnostic product research and development and currently has no commercial sales of vaccines, treatments, or diagnostic products.

This Amendment reports events as of the filing date of the Original 8-K and does not reflect events that may have occurred subsequent to the original filing date, and except as described above, no other changes have been made to the Original 8-K.
Entity Central Index Key0001636051
Document Period End DateMar. 11,
Entity Emerging Growth Companytrue
Entity Ex Transition Periodfalse
Entity Incorporation, State or Country CodeNV
Entity File Number333-202948
Entity Tax Identification Number47-1017473
Entity Address, Address Line One805 W. Duarte Rd., Suite 102
Entity Address, City or TownArcadia
Entity Address, State or ProvinceCA
Entity Address, Postal Zip Code91007
City Area Code(626)
Local Phone Number210-0000
Written Communicationstrue
Soliciting Materialtrue
Pre-commencement Tender Offertrue
Pre-commencement Issuer Tender Offertrue
Title of 12(b) SecurityNone
No Trading Symbol Flagtrue
Security Exchange NameNONE